Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christine Duncan, MD
Dana-Farber Cancer Institute
Study Chair - K. Scott Baker, MD
Fred Hutchinson Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Scottsdale, Arizona, United States
- University of Arizona Medical Center
Tucson, Arizona, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Ucla Center for Health Sciences
Los Angeles, California, United States
- Children'S Hospital & Research Center - Oakland
Oakland, California, United States
- University of California San Francisco Medical Center
San Francisco, California, United States
- University of Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Ann and Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Indiana University Hospital/riley Hospital for Children
Indianapolis, Indiana, United States
- Dana Farber Cancer Institute - Pediatrics
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- the Children'S Mercy Hospitals and Clinics
Kansas City, Missouri, United States
- Washington University/st. Louis Children'S Hospital
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Westchester Medical Center
Valhalla, New York, United States
- University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
- Levine Children'S Hospital
Charlotte, North Carolina, United States
- Duke University Medical Center - Pediatrics
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Oregon Health and Science University - Doernbecher Children'S Hospital
Portland, Oregon, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Children'S Medical Center Dallas
Dallas, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Primary Children'S Hospital
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 30 Sept 2020
- Completion
- 31 Dec 2023
- Last update posted
- 8 Feb 2023
- Registered enrollment
- 340
- Registry id
- NCT02338479
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.